Kyntra Bio, Inc.

US$3.73As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KYNBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (37.49%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.11
PE TTM 0.082
TSR TTM (66.46%)
Mkt cap US$15.10M
ROIC (68.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.64
(2.31%)
(88.17%)
Hold 5|12|10|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.04
25.54%
24.12%
6.88%
(5.24%)
Revenue$M
0.807
0.793
0.803
0.818
4.98%
1.04%
3.66%
3.32%
Peers (US$15.10M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.618
(0.143)
(0.162)
EBIT/Intx
0.548
0.097
0.105
Own earn%
81.63
159.54
146.45
Sh yield%
26.22
27.42
29.04
Owners
Insiders/Inst%
12.81
81.99
Short interest%
4.86
SBC / revenue%
2.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
1–12
$1 testx
0.0
Incr. ROIC%
22